Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

User Fees In Administration's Budget Request Aimed At Third-Party Program

This article was originally published in The Gray Sheet

Executive Summary

FDA's Center for Devices and Radiological Health is hoping that the most recent user fee proposal set forth in the administration's FY 2001 budget request might breathe some life into the agency's moribund 510(k) third-party review program.
Advertisement

Related Content

Device User Fee Discussions Could Resurface During 107th Congress
Device User Fee Discussions Could Resurface During 107th Congress
FDA Offers $4,000 To Cover Cost Of Third-Party Review Expenses
FDA Offers $4,000 To Cover Cost Of Third-Party Review Expenses
MDMA Challenges Purchasing Groups In Public Policy Agenda For 2000
MDMA Challenges Purchasing Groups In Public Policy Agenda For 2000
FDA Considers Expanding Third-Party List Without Related Guidances
FDA Considers Expanding Third-Party List Without Related Guidances
FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee
Advertisement
UsernamePublicRestriction

Register

MT012963

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel